hierarchy 发表于 2025-3-21 18:42:38

书目名称Cancer Immunology影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0221126<br><br>        <br><br>书目名称Cancer Immunology读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0221126<br><br>        <br><br>

结构 发表于 2025-3-21 22:36:42

R. Achatzy,F. Daschner,N. Pittlik,F. Bartelsd encouraging results have been demonstrated both preclinically and in clinical trials. In this chapter we summarize the immunotherapeutic strategies for multiple myeloma together with the most up-to-date clinical trial outcomes.

高脚酒杯 发表于 2025-3-22 01:27:58

B. Roth,G. Mattarelli,F. Bartelsoverview of candidate antigens to target in AML is given, followed by the currently described passive and active immunotherapeutic strategies. Active immunotherapy (e.g., modified leukemic cells, peptide, DNA, or dendritic cell-based vaccinations) requires a patient with an intact immune system and

ITCH 发表于 2025-3-22 08:06:37

http://reply.papertrans.cn/23/2212/221126/221126_4.png

狂热语言 发表于 2025-3-22 09:10:57

http://reply.papertrans.cn/23/2212/221126/221126_5.png

性别 发表于 2025-3-22 15:29:57

Joachim H.R. Lübke,Astrid Rollenhagennogenesis and progression has been unveiled. Cytokines and lymphokines such as interleukin-6 and lymphotoxin, together with immune cells such as tumor-associated macrophages, play an important role in this process. Disruption in normal immune regulatory mechanisms provides additional therapeutic tar

性别 发表于 2025-3-22 20:18:30

Joachim H.R. Lübke,Astrid Rollenhagenhocytes (Treg). The present knowledge of the tumor microenvironment at the molecular and cellular levels is being used to reverse the situation in favor of the patient through targeted therapies such as the use of tyrosine kinase inhibitors or procedures that specifically activate an immune reaction

希望 发表于 2025-3-23 00:04:15

http://reply.papertrans.cn/23/2212/221126/221126_8.png

Individual 发表于 2025-3-23 04:27:13

Martin Middeke,Heinrich Holzgrevemor rejection rather than tolerance. This chapter will provide an overview of the immunomodulatory effects of nonsteroidal anti-inflammatory drugs (NSAIDs), statins, selective estrogen response modulators (SERMs), rexinoids, antidiabetic drugs, and natural agents (triterpenoids, phytochemicals, fatt

钢笔尖 发表于 2025-3-23 08:47:15

Joseph A. Ball,Israel Gohberg,Leiba Rodmannt treatment options and are held responsible for the initiation, metastasis, and recurrence of the disease. Thus, investigations on the interaction of CSCs with the host immune system have been performed, and targeting CSCs will potentially result in improved therapeutic outcome in the future.
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im